Ranbaxy Laboratories Ltd has received the US Food and Drug Administration's approval to market Fosinopril sodium tablets in the United States.
The USFDA website on Monday said that the company had been given the go-ahead for marketing Fosinopril sodium indicated for the treatment of hypertension.